Vodafone’s German Operations Show Growth; AstraZeneca Exceeds Profit Expectations

Vodafone’s German subsidiary has rebounded, while AstraZeneca reports a higher-than-expected profit driven by strong demand for cancer therapies. Vodafone’s German operations have returned to growth after a previous decline, with service revenues increasing by approximately two percent to €2.74 billion.…









